Evaluating the prognostic impact of EGFR mutation on adjuvant chemotherapy efficacy in grade 3 stage IB lung adenocarcinoma. An Z, Ning Y, Mei J, Yang C, et al. Lung Cancer 2025;202:108507.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

An Z, Ning Y, Mei J, Yang C, et al. Evaluating the prognostic impact of EGFR mutation on adjuvant chemotherapy efficacy in grade 3 stage IB lung adenocarcinoma. Lung Cancer 2025;202:108507.
PMID: 40132294